Bladder Cancer - Results from #120

Therapeutic Landscape Beyond Immunotherapy in Advanced Urothelial Carcinoma: Moving Past the Checkpoint. December 1, 2022

Non-urothelial and urothelial variants of bladder cancer. December 1, 2022

New Mental Health Diagnosis as a Prognostic Factor for Muscle-Invasive Bladder Cancer. December 1, 2022

Multiparametric MRI for Diagnosis and Staging of Bladder Cancer - Expert Commentary November 30, 2022

Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis. November 30, 2022

Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond. November 30, 2022

Novel synthetic lethality drug target in urothelial bladder cancer based on MTAP genomic loss. November 30, 2022

Genentech Provides Update on Tecentriq U.S. Indication for Previously Untreated Metastatic Bladder Cancer November 29, 2022

Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy. November 29, 2022

25 years International Bladder Cancer Network (IBCN): The past, the present, and the future. November 29, 2022

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups. November 29, 2022

Genomic Biomarkers for Response to Chemotherapy in Bladder Cancer Patients - Expert Commentary November 28, 2022

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial. November 28, 2022

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma. November 28, 2022

Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? November 28, 2022

Treatment decisions of bladder cancer in patients older than 85 years: a SEER-based analysis 2011-2015. November 25, 2022

Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry. November 25, 2022

Preliminary Surgical Outcomes After Single Incision Robotic Cystectomy (SIRC). November 24, 2022

Complications in urological surgery: Bladder surgery. November 24, 2022

Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. November 23, 2022

Page 7 of 453

email news signup